Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
207.00    -3.50 (-1.66%)
Bid:
205.50
Ask:
206.00
Spread: 0.50 (0.243%)
Market Cap: £551.69m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

Director/PDMR Shareholding

7 Apr 2016 07:00

RNS Number : 4131U
Costain Group PLC
07 April 2016
Β 

Costain Group PLC("Costain" or "the Company")

The following notification is made in accordance with DTR 3.1.4R (1) (a).

Β 

Costain Group PLC announces the following grant of share awards to certain directors of the Company under the Share Deferral Plan and the Company's Long Term Incentive Plan as detailed in sections (A) and (B) below.

(A) Costain Group PLC 2014 Share Deferral Plan

Β 

On 06 April 2016, awards over ordinary shares of 50p each in the Company were made under the Costain Group PLC 2014 Share Deferral Plan (the "Share Deferral Plan").

Β 

The awards granted under the Share Deferral Plan are structured as options with a nil exercise price over a number of shares (the "Awards"). No consideration was paid for the grant of the Awards.

Awards were made to the following Executive Directors:

Name of Director

Number of Shares Under the Awards

Andrew Wyllie

51,643

Anthony Bickerstaff

34,428

Β 

The Awards will become exercisable on or around the second anniversary of the date of grant subject to the Rules of the Share Deferral Plan and the continued employment of the participants. To the extent that all or any part of the Awards become exercisable, they will remain exercisable until the day before the tenth anniversary of the date of grant provided the individual remains an employee or officer of the Company.

Β 

(B) Costain Group PLC 2014 Long Term Incentive Plan

On 06 April 2016, awards under the Costain Group PLC 2014 Long Term Incentive Plan (the "LTIP") were made over ordinary shares of 50p each in the Company in the form of nil-cost options (the "Awards").

No consideration was paid for the grant of the Awards.

The vesting of the Awards is subject to the satisfaction of certain performance conditions. The Annual Report 2015 included proposed performance conditions. The performance conditions have now been finalised by the Remuneration Committee of the Company and are as follows: an EPS target of 91.7p (for 15% vesting) and 101.7p (for 100% vesting), with vesting on a straight-line basis between the two. 50% of the Awards will normally vest three years after grant, subject to the satisfaction of performance conditions over the three year financial period ending 31 December 2018, whilst the remaining 50% of the Awards will normally vest on the fifth anniversary of the date of grant (with no further performance conditions required). The Awards will remain exercisable from the date of vesting of each half of the Awards until the day before the tenth anniversary of the date of grant provided the individual remains an employee or officer of the Company.

Awards were made to the following Executive Directors:

Name of Director

Number of Shares subject to the Award

Andrew Wyllie

132,678

Anthony Bickerstaff

87,913

The Company was informed of the above transactions on 06 April 2016.

Β 

07 April 2016

Enquiries:

Costain Group PLC Tel: 01628 842444Tracey Wood

Company Secretary

Β 

Instinctif Partners

Tel: 020 7457 2020

Mark Garraway

Helen Tarbet

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHSSEFIMFMSEDL
Date   Source Headline
7th Nov 202510:18 amRNSHolding(s) in Company
4th Nov 20254:25 pmRNSHolding(s) in Company
3rd Nov 20251:30 pmRNSHolding(s) in Company
3rd Nov 202511:59 amRNSTotal Voting Rights
30th Oct 20253:08 pmRNSHolding(s) in Company
28th Oct 20252:48 pmRNSHolding(s) in Company
27th Oct 20252:47 pmRNSHolding(s) in Company
24th Oct 202512:05 pmRNSHolding(s) in Company
21st Oct 20254:13 pmRNSHolding(s) in Company
17th Oct 20255:07 pmRNSHolding(s) in Company
17th Oct 202511:26 amRNSHolding(s) in Company
14th Oct 20253:34 pmRNSAdditional Listing
13th Oct 202511:42 amRNSDirector/PDMR Shareholding
13th Oct 20257:00 amRNSCostain Secures £1bn Programme With Sellafield
6th Oct 202510:59 amRNSHolding(s) in Company
18th Sep 20252:00 pmRNSScrip Dividend Reference Price
1st Sep 202511:07 amRNSTotal Voting Rights
28th Aug 20259:05 amRNSDirector/PDMR Shareholding
22nd Aug 20253:28 pmRNSHolding(s) in Company
22nd Aug 20257:00 amRNSDirector/PDMR Shareholding
20th Aug 20257:00 amRNSHalf-year Report
18th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20257:00 amRNSTransaction in Own Shares
14th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20259:07 amRNSHolding(s) in Company
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20255:23 pmRNSHolding(s) in Company
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 20252:39 pmRNSHolding(s) in Company
5th Aug 20257:00 amRNSTransaction in Own Shares
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 202510:47 amRNSHolding(s) in Company
1st Aug 202510:00 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 202510:40 amRNSHolding(s) in Company
31st Jul 20257:00 amRNSTransaction in Own Shares
30th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20253:03 pmRNSHolding(s) in Company
29th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20257:00 amRNSInvestor Presentation via Investor Meet Company
28th Jul 20252:11 pmRNSHolding(s) in Company
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20252:25 pmRNSHolding(s) in Company
25th Jul 20257:00 amRNSTransaction in Own Shares
24th Jul 20257:00 amRNSTransaction in Own Shares
23rd Jul 202511:03 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.